View in EDS

Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability.

Saved in:
Bibliographic Details
Title: Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability.
Authors: Supiot R; Putnam Associates, HTA & Market Access, Paris, France. Electronic address: romain.supiot@putassoc.com., du Manoir de Juaye L; Roche S.A.S, Health Economics Unit, Boulogne-Billancourt, France., Chouaid C; Centre Hospitalier Intercommunal de Créteil (CHIC), Service de Pneumologie, Créteil, France; Université Paris-Est Créteil (UPEC), Créteil, France. Electronic address: Christos.chouaid@chicreteil.fr.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Mar; Vol. 213, pp. 108944. Date of Electronic Publication: 2026 Jan 26.
Publication Type: Letter
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41604756
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Supiot+R%22">Supiot R</searchLink>; Putnam Associates, HTA & Market Access, Paris, France. Electronic address: romain.supiot@putassoc.com.<br /><searchLink fieldCode="AU" term="%22du+Manoir+de+Juaye+L%22">du Manoir de Juaye L</searchLink>; Roche S.A.S, Health Economics Unit, Boulogne-Billancourt, France.<br /><searchLink fieldCode="AU" term="%22Chouaid+C%22">Chouaid C</searchLink>; Centre Hospitalier Intercommunal de Créteil (CHIC), Service de Pneumologie, Créteil, France; Université Paris-Est Créteil (UPEC), Créteil, France. Electronic address: Christos.chouaid@chicreteil.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228800805%22">Lung cancer (Amsterdam, Netherlands)</searchLink> [Lung Cancer] 2026 Mar; Vol. 213, pp. 108944. <i>Date of Electronic Publication: </i>2026 Jan 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8800805 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-8332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201695002%22">01695002 </searchLink><i>NLM ISO Abbreviation: </i>Lung Cancer <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41604756
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2026.108944
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108944
    Titles:
      – TitleFull: Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Supiot R
      – PersonEntity:
          Name:
            NameFull: du Manoir de Juaye L
      – PersonEntity:
          Name:
            NameFull: Chouaid C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1872-8332
          Numbering:
            – Type: volume
              Value: 213
          Titles:
            – TitleFull: Lung cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1